Menna R. Clatworthy

Menna R. Clatworthy

Auto-generated profile, based on publicly available information

Menna R. Clatworthy

Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2022 in Science
Verified
Journal Article
Open access
CCC. Domínguez Conde
C. Domínguez Conde
CXC. Xu
C. Xu
LJL. B. Jarvis
L. B. Jarvis
DRD. B. Rainbow
D. B. Rainbow
SWS. B. Wells
S. B. Wells
STS. A. Teichmann
S. A. Teichmann
Despite their crucial role in health and disease, our knowledge of immune cells within human tissues remains limited. We surveyed the immune compartment of 16 tissues from 12 adult donors by single-cell RNA sequencing and VDJ sequencing generating a dataset of ~360,000 cells. To systematically resolve immune cell heterogeneity across tissues, we developed CellTypist, a machine learning tool for rapid and precise cell type annotation. Using this approach, combined with detailed curation, we determined the tissue distribution of finely phenotyped immune cell types, revealing hitherto unappreciated tissue-specific features and clonal architecture of T and B cells. Our multitissue approach lays the foundation for identifying highly resolved immune cell types by leveraging a common reference dataset, tissue-integrated expression analysis, and antigen receptor sequencing.

20 April 2021 in Nature Medicine
Verified
Journal Article
Open access
PDF file
ESEmily Stephenson
Emily Stephenson
GRGary Reynolds
Gary Reynolds
RBRachel A. Botting
Rachel A. Botting
FCFernando J. Calero-Nieto
Fernando J. Calero-Nieto
MMMichael D. Morgan
Michael D. Morgan
MHMuzlifah Haniffa
Muzlifah Haniffa
Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). We performed single-cell transcriptome, surface proteome and T and B lymphocyte antigen receptor analyses of over 780,000 peripheral blood mononuclear cells from a cross-sectional cohort of 130 patients with varying severities of COVID-19. We identified expansion of nonclassical monocytes expressing complement transcripts (CD16+C1QA/B/C+) that sequester platelets and were predicted to replenish the alveolar macrophage pool in COVID-19. Early, uncommitted CD34+hematopoietic stem/progenitor cells were primed toward megakaryopoiesis, accompanied by expanded megakaryocyte-committed progenitors and increased platelet activation. Clonally expanded CD8+T cells and an increased ratio of CD8+effector T cells to effector memory T cells characterized severe disease, while circulating follicular helper T cells accompanied mild disease. We observed a relative loss of IgA2 in symptomatic disease despite an overall expansion of plasmablasts and plasma cells. Our study highlights the coordinated immune response that contributes to COVID-19 pathogenesis and reveals discrete cellular components that can be targeted for therapy.

21 February 2020 in Science
Verified
Journal Article
Closed access
PDF file
JPJong-Eun Park
Jong-Eun Park
RBRachel A. Botting
Rachel A. Botting
CCCecilia Domínguez Conde
Cecilia Domínguez Conde
DPDorin-Mirel Popescu
Dorin-Mirel Popescu
MLMarieke Lavaert
Marieke Lavaert
STSarah A. Teichmann
Sarah A. Teichmann
Thymus development, cell by cell: The human thymus is the organ responsible for the maturation of many types of T cells, which are immune cells that protect us from infection. However, it is not well known how these cells develop with a full immune complement that contains the necessary variation to protect us from a variety of pathogens. By performing single-cell RNA sequencing on more than 250,000 cells, Park et al. examined the changes that occur in the thymus over the course of a human life. They found that development occurs in a coordinated manner among immune cells and with their developmental microenvironment. These data allowed for the creation of models of how T cells with different specific immune functions develop in humans. Science , this issue p. eaay3224

10 August 2018 in Science
Verified
Journal Article
Closed access
PDF file
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
FBFelipe A. Vieira Braga
Felipe A. Vieira Braga
MTMaxine G. B. Tran
Maxine G. B. Tran
BSBenjamin J. Stewart
Benjamin J. Stewart
SBSam Behjati
Sam Behjati
Pediatric and adult kidney tumors differ: Understanding tumor origins and the similarities and differences between organ-specific cancers is important for determining treatment options. Young et al. generated more than 72,000 single-cell transcriptomes from healthy and cancerous human kidneys. From these data, they determined that Wilms tumor, a pediatric kidney cancer, originates from aberrant fetal cells, whereas adult kidney cancers are likely derived from a specific subtype of proximal convoluted tubular cell. Science , this issue p. 594

27 September 2019 in Science
Verified
Journal Article
Closed access
PDF file
BSBenjamin J. Stewart
Benjamin J. Stewart
JFJohn R. Ferdinand
John R. Ferdinand
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
KLKevin W. Loudon
Kevin W. Loudon
MCMenna R. Clatworthy
Menna R. Clatworthy
Immune landscape of the human kidney: Single-cell RNA sequencing has begun to shed light on the full cellular diversity of specific organs. However, these studies rarely examine organ-specific immune cells. Stewart et al. sequenced healthy adult and fetal kidney samples at a single-cell level to define the heterogeneity in epithelial, myeloid, and lymphoid cells. From this dataset, they identified zonation of cells, with relevance to disease and the varied perturbations that occur in different tumor settings. This profiling of the human kidney generates a comprehensive census of existing cell populations that will help inform the diagnosis and treatment of kidney-related diseases. Science , this issue p. 1461

31 December 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
EME. Madissoon
E. Madissoon
AWA. Wilbrey-Clark
A. Wilbrey-Clark
RMR. J. Miragaia
R. J. Miragaia
KSK. Saeb-Parsy
K. Saeb-Parsy
KMK. T. Mahbubani
K. T. Mahbubani
KMK. B. Meyer
K. B. Meyer
Background: The Human Cell Atlas is a large international collaborative effort to map all cell types of the human body. Single-cell RNA sequencing can generate high-quality data for the delivery of such an atlas. However, delays between fresh sample collection and processing may lead to poor data and difficulties in experimental design. Results: This study assesses the effect of cold storage on fresh healthy spleen, esophagus, and lung from ≥ 5 donors over 72 h. We collect 240,000 high-quality single-cell transcriptomes with detailed cell type annotations and whole genome sequences of donors, enabling future eQTL studies. Our data provide a valuable resource for the study of these 3 organs and will allow cross-organ comparison of cell types. We see little effect of cold ischemic time on cell yield, total number of reads per cell, and other quality control metrics in any of the tissues within the first 24 h. However, we observe a decrease in the proportions of lung T cells at 72 h, higher percentage of mitochondrial reads, and increased contamination by background ambient RNA reads in the 72-h samples in the spleen, which is cell type specific. Conclusions: In conclusion, we present robust protocols for tissue preservation for up to 24 h prior to scRNA-seq analysis. This greatly facilitates the logistics of sample collection for Human Cell Atlas or clinical studies since it increases the time frames for sample processing.